"Myriam is a veteran healthcare executive and trained surgeon with extensive experience overseeing clinical and regulatory affairs," said
Dr. Curet joined
"I'm very impressed by Nektar's visionary leadership team, proven science and R&D pipeline of investigational therapeutics for patients suffering from cancer and autoimmune disorders," said Dr. Curet. "I'm looking forward to collaborating with Nektar's executives and other members of its world-class Board to provide strategic guidance as the company continues to advance its innovative product candidates through clinical trials with the goal of delivering them to patients in need."
Dr. Curet received a bachelor's degree from